Biohaven Ltd


Market Cap$2.95B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biohaven LtdBiohaven Ltd00%128%3.7-1.3

Target Price by Analysts

74.9% upsideBiohaven Ltd Target Price DetailsTarget Price

Current Fair Value

90.8% downside

Overvalued by 90.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.95 Billion
Enterprise Value$3.40 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares88,291,909
Avg 30 Day Volume1,350,247


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales3.72
Price to Book Ratio-3.34
Enterprise Value to Revenue3.96
Enterprise Value to EBIT-5.28
Enterprise Value to Net Income-4
Total Debt to Enterprise0.3
Debt to Equity-1.26

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Biohaven Pharmaceutical Holding Company Ltd

CEO: Vlad Coric